124,534 Shares in Bausch Health Companies Inc. (NYSE:BHC) Bought by Range Financial Group LLC

Range Financial Group LLC purchased a new position in Bausch Health Companies Inc. (NYSE:BHC) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 124,534 shares of the company’s stock, valued at approximately $1,004,000.

A number of other institutional investors have also bought and sold shares of BHC. Headlands Technologies LLC bought a new position in Bausch Health Companies during the second quarter worth $35,000. MQS Management LLC acquired a new position in Bausch Health Companies during the second quarter worth $71,000. Certuity LLC bought a new position in shares of Bausch Health Companies in the second quarter valued at $75,000. Kendall Capital Management acquired a new position in shares of Bausch Health Companies during the second quarter valued at about $87,000. Finally, Brown Brothers Harriman & Co. bought a new stake in shares of Bausch Health Companies during the second quarter worth about $109,000. Institutional investors own 78.65% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. StockNews.com raised shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a research report on Friday, October 25th. Evercore ISI raised Bausch Health Companies to a “hold” rating in a research report on Tuesday, October 15th. Finally, Royal Bank of Canada increased their price target on Bausch Health Companies from $10.00 to $11.00 and gave the company a “sector perform” rating in a research report on Friday, November 1st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $7.75.

Bausch Health Companies Stock Up 0.5 %

Bausch Health Companies stock traded up $0.04 during trading on Tuesday, hitting $7.84. The stock had a trading volume of 816,999 shares, compared to its average volume of 939,080. The stock has a market cap of $2.84 billion, a price-to-earnings ratio of -16.33 and a beta of 0.69. The stock’s 50 day moving average is $8.23 and its two-hundred day moving average is $7.40. Bausch Health Companies Inc. has a 1 year low of $3.96 and a 1 year high of $11.46.

Bausch Health Companies (NYSE:BHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.02 by $0.10. Bausch Health Companies had a negative net margin of 1.88% and a negative return on equity of 755.86%. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.42 billion. During the same period in the prior year, the firm earned $1.03 earnings per share. The company’s revenue was up 12.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Bausch Health Companies Inc. will post 3.74 EPS for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.